Terms: = Kidney tumors AND CTCF, P49711, 10664, ENSG00000102974 AND Treatment
5 results:
1. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract] [Full Text] [Related]
2. CircESRP1 inhibits clear cell renal cell carcinoma progression through the ctcf-mediated positive feedback loop.
Gong LJ; Wang XY; Yao XD; Wu X; Gu WY
Cell Death Dis; 2021 Nov; 12(11):1081. PubMed ID: 34775467
[TBL] [Abstract] [Full Text] [Related]
3. QPCT regulation by ctcf leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis.
Zhao T; Zhou Y; Wang Q; Yi X; Ge S; He H; Xue S; Du B; Ge J; Dong J; Qu L; Wang L; Zhou W
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34036385
[TBL] [Abstract] [Full Text] [Related]
4. Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma.
Zhou X; Tolstov Y; Arslan A; Roth W; Grüllich C; Pahernik S; Hohenfellner M; Duensing S
Neoplasia; 2014 Dec; 16(12):1028-35. PubMed ID: 25499216
[TBL] [Abstract] [Full Text] [Related]
5. Loss of imprinting and cancer.
Jelinic P; Shaw P
J Pathol; 2007 Feb; 211(3):261-8. PubMed ID: 17177177
[TBL] [Abstract] [Full Text] [Related]
